Atherosclerosis and Lipoproteins |
From the Division of Cardiovascular and Respiratory Medicine, Departments of Internal Medicine (M.O., N.I., T.S., Y.S., K.-i.H., S.K., M.Y.) and Surgical Pathology (H.A., Y.H., H.I.), Kobe University Graduate School of Medicine, Kobe, and the Department of Biological Response (J.Y.), Institute for Virus Research, Kyoto University, Kyoto, Japan.
Correspondence to Nobutaka Inoue, Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, chuo-ku, Kobe, 650-0017, Japan. E-mail nobutaka{at}med.kobe-u.ac.jp
Abstract Oxidative stress is considered an important factor in atherogenesis. Mammalian cells have a complex network of antioxidants such as catalase, superoxide dismutase, and glutathione peroxidase. However, the mechanisms that regulate the cellular redox state in the vessel wall remain unclear. Recent study has shown that thioredoxin, a thiol-disulfide oxidoreductase, is expressed in atherosclerotic plaques of human carotid arteries. In this study, we investigated the localization and expressional change of glutaredoxin and thioredoxin, two important members of the thiol-disulfide oxidoreductases, in autopsy samples of human coronary arteries. In nonatherosclerotic coronary arteries, glutaredoxin was expressed in endothelial cells, in fibroblasts of the adventitia, and most intensely in medial smooth muscle cells. Interestingly, in atherosclerotic lesions such as hypercellular lesions, the infiltrating macrophages highly expressed glutaredoxin. The expressional pattern of thioredoxin was quite similar to that of glutaredoxin. Western blot analysis demonstrated that hydrogen peroxide stimulated the expression of glutaredoxin in a time- and dose-dependent manner in cultured human coronary artery smooth muscle cells. Fluorescence microtopography with dihydroethidium demonstrated that the generation of reactive oxygen species was associated with the expression of glutaredoxin. These results suggest the possible involvement of thiol-disulfide oxidoreductases in antioxidant protection in human coronary arteries.
Key Words: antioxidants atherosclerosis coronary artery disease free radicals
This article has been cited by other articles:
![]() |
T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-a. Okabe, K. Shimada, M. Hattori, T. Murayama, M. Yokode, T. Kita, and C. Kishimoto Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects Cardiovasc Res, June 1, 2007; 74(3): 537 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi-Miura, K. Shioji, Y. Hoshino, H. Masutani, H. Nakamura, and J. Yodoi Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2040 - H2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, Y. Luo, W. Zhang, Y. He, S. Dai, R. Zhang, Y. Huang, P. Bernatchez, F. J. Giordano, G. Shadel, et al. Endothelial-Specific Expression of Mitochondrial Thioredoxin Improves Endothelial Cell Function and Reduces Atherosclerotic Lesions Am. J. Pathol., March 1, 2007; 170(3): 1108 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berndt, C. H. Lillig, and A. Holmgren Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1227 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sykes, A. L. Mowbray, and H. Jo Reversible Glutathiolation of Caspase-3 by Glutaredoxin as a Novel Redox Signaling Mechanism in Tumor Necrosis Factor-{alpha}-Induced Cell Death Circ. Res., February 2, 2007; 100(2): 152 - 154. [Full Text] [PDF] |
||||
![]() |
A. D. Gosbell, N. Stefanovic, L. L. Scurr, J. Pete, I. Kola, I. Favilla, and J. B. de Haan Retinal light damage: structural and functional effects of the antioxidant glutathione peroxidase-1. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2613 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. de Haan, P. K. Witting, N. Stefanovic, J. Pete, M. Daskalakis, I. Kola, R. Stocker, and J. J. Smolich Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet J. Lipid Res., June 1, 2006; 47(6): 1157 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayr, Y.-L. Chung, U. Mayr, X. Yin, L. Ly, H. Troy, S. Fredericks, Y. Hu, J. R. Griffiths, and Q. Xu Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2135 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, Z. Xu, S. Li, and G. J. Rozanski Redox regulation of Ito remodeling in diabetic rat heart Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1417 - H1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamawaki, J. Haendeler, and B. C. Berk Thioredoxin: A Key Regulator of Cardiovascular Homeostasis Circ. Res., November 28, 2003; 93(11): 1029 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ejiri, N. Inoue, T. Tsukube, T. Munezane, Y. Hino, S. Kobayashi, K.-i. Hirata, S. Kawashima, S. Imajoh-Ohmi, Y. Hayashi, et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: Protective role of statin and angiotensin II type 1 receptor blocker Cardiovasc Res, October 1, 2003; 59(4): 988 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manzoni, M. Duranti, I. Eberini, H. Scharnag, W. Marz, S. Castiglioni, and M. R. Lovati Subcellular Localization of Soybean 7S Globulin in HepG2 Cells and LDL Receptor Up-Regulation by Its {alpha}' Constituent Subunit J. Nutr., July 1, 2003; 133(7): 2149 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawashima, T. Yamashita, Y. Miwa, M. Ozaki, M. Namiki, T. Hirase, N. Inoue, K.-i. Hirata, and M. Yokoyama HMG-CoA Reductase Inhibitor Has Protective Effects Against Stroke Events in Stroke-Prone Spontaneously Hypertensive Rats Stroke, January 1, 2003; 34(1): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |